← All trials
NCT03125577
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2017
- Primary completion
- Jul 1, 2019
- Completion date
- Dec 1, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 100
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Shenzhen Geno-Immune Medical InstituteLead sponsor
- Shenzhen Geno-Immune Medical InstituteOverall official - principal investigator
- Shenzhen Geno-Immune Medical InstituteReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.